Welcome to Minding Memory. In this podcast we discuss topics related to dementia research. This is an all-hands-on-deck moment for dementia research, and we have topics for both those new to the space as well as old pros. We start with some basics, like: What exactly is dementia? What are the different types of dementia? What is the TICS, if not a swarm of blood-sucking insects? But we also invite researchers on to discuss their interesting work to give you a glimpse at the questions, data, and methods moving the field forward.
Minding Memory is co-hosted by Matthew Davis and Lauren Gerlach. Matt and Lauren are health services researchers and professors at the University of Michigan. Matt’s PhD is in Data Science and Lauren is a geriatric psychiatrist. The Minding Memory podcast is part of the Center to Accelerate Population Research in Alzheimer’s (CAPRA) at the University of Michigan, supported by the National Institute on Aging at the National Institutes of Health. Additional support also comes from the Institute for Healthcare Policy and Innovation. The content of this podcast does not represent the views of the National Institutes of Health or the University of Michigan. Please consider subscribing to this podcast and make sure to check out our website. On our website you’ll also find links to the center’s seminar series and data products created specifically for dementia research.
You can subscribe to Minding Memory on Apple Podcasts, Spotify, or wherever you listen to podcasts.
Hosted on Acast. See acast.com/privacy for more information.
Welcome to Minding Memory. In this podcast we discuss topics related to dementia research. This is an all-hands-on-deck moment for dementia research, and we have topics for both those new to the space as well as old pros. We start with some basics, like: What exactly is dementia? What are the different types of dementia? What is the TICS, if not a swarm of blood-sucking insects? But we also invite researchers on to discuss their interesting work to give you a glimpse at the questions, data, and methods moving the field forward.
Minding Memory is co-hosted by Matthew Davis and Lauren Gerlach. Matt and Lauren are health services researchers and professors at the University of Michigan. Matt’s PhD is in Data Science and Lauren is a geriatric psychiatrist. The Minding Memory podcast is part of the Center to Accelerate Population Research in Alzheimer’s (CAPRA) at the University of Michigan, supported by the National Institute on Aging at the National Institutes of Health. Additional support also comes from the Institute for Healthcare Policy and Innovation. The content of this podcast does not represent the views of the National Institutes of Health or the University of Michigan. Please consider subscribing to this podcast and make sure to check out our website. On our website you’ll also find links to the center’s seminar series and data products created specifically for dementia research.
You can subscribe to Minding Memory on Apple Podcasts, Spotify, or wherever you listen to podcasts.
Hosted on Acast. See acast.com/privacy for more information.
In this episode of Minding Memory, we dive into the newest FDA-approved drug to treat Alzheimer’s – Lecanemab – with Ohio State University stroke neurologist Jim Burke. Dr. Burke discusses the benefits and drawbacks of the new Alzheimer’s drug and also the paradigm shift of how people (clinicians, patients, and the general population) are thinking about these news Alzheimer’s medications.
Jim Burke Faculty Profile: https://wexnermedical.osu.edu/find-a-doctor/james-burke-md-128794
Article referenced in podcast: Burke JF, Richard S, Langa KM, Albin RL, Kotagal V. Lecanemab: Looking Before We Leap. Neurology. 2023 Jul 21: doi: 10.1212/WNL.0000000000207505. Epub ahead of print. PMID: 37479527.
The transcript for this episode can be found here.
CAPRA Website: http://capra.med.umich.edu/
You can subscribe to Minding Memory on Apple Podcasts, Spotify, Google Podcasts or wherever you listen to podcasts.
Hosted on Acast. See acast.com/privacy for more information.